Literature DB >> 18347509

Assessment and grading of mucosal inflammation in colonic diverticular disease.

Antonio Tursi1, Giovanni Brandimarte, Walter Elisei, Gian Marco Giorgetti, Cosimo Damiano Inchingolo, Silvio Danese, Fabio Aiello.   

Abstract

GOAL: The aim of this study was to assess and grade the mucosal inflammatory infiltrate in different degrees of diverticular disease (DD) and to compare them with healthy matched controls.
BACKGROUND: Mucosal inflammation in colonic DD has never been investigated. In particular, it is unknown whether inflammation may be found in every degree of DD.
MATERIALS AND METHODS: Thirty consecutive patients with a new endoscopic diagnosis of DD (10 with asymptomatic diverticulosis, 10 with symptomatic uncomplicated DD, and 10 with acute uncomplicated diverticulitis) and 10 healthy controls were studied.
RESULTS: A neutrophilic inflammatory infiltrate was found only in acute uncomplicated diverticulitis (overall score, 26). The mean lymphocytic cell density was significantly higher in symptomatic DD (median lymphocytic density, 7) and acute uncomplicated diverticulitis (median lymphocytic density, 11). Subdividing the patients according to different degrees of DD, we found higher lymphocytic cell density even in asymptomatic diverticulosis (median lymphocytic density, 6.5) than healthy controls (median lymphocytic density, 4; P<0.02).
CONCLUSIONS: We found an increased inflammatory infiltrate in DD according to the degree of the disease and higher than healthy controls. Moreover, also asymptomatic diverticulosis shows higher inflammatory cell density than controls.

Entities:  

Mesh:

Year:  2008        PMID: 18347509     DOI: 10.1097/MCG.0b013e3180653ca2

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  26 in total

Review 1.  Segmental colitis associated with diverticulosis: complication of diverticular disease or autonomous entity?

Authors:  Antonio Tursi
Journal:  Dig Dis Sci       Date:  2010-04-22       Impact factor: 3.199

2.  Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.

Authors:  Liying Dai; Denis W King; D Shevy Perera; David Z Lubowski; Elizabeth Burcher; Lu Liu
Journal:  Dig Dis Sci       Date:  2015-02-11       Impact factor: 3.199

3.  Preventing recurrent acute diverticulitis with pharmacological therapies.

Authors:  Antonio Tursi
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

Review 4.  Advances in the management of colonic diverticulitis.

Authors:  Antonio Tursi
Journal:  CMAJ       Date:  2012-08-27       Impact factor: 8.262

Review 5.  Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.

Authors:  Antonio Tursi; Raymond E Joseph; Paul Streck
Journal:  Dig Dis Sci       Date:  2011-05-13       Impact factor: 3.199

6.  Diverticular disease: A therapeutic overview.

Authors:  Antonio Tursi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-02-06

Review 7.  Management of Diverticular Disease in the Setting of Other Colorectal Pathology: Data on Simultaneous Issues in Segmental Colitis, Inflammatory Bowel Disease, Cancer, and Complications.

Authors:  Nasrin Ghalyaie
Journal:  Clin Colon Rectal Surg       Date:  2018-06-22

Review 8.  Epidemiology and Pathophysiology of Diverticular Disease.

Authors:  Semeret T Munie; Surya P M Nalamati
Journal:  Clin Colon Rectal Surg       Date:  2018-06-22

Review 9.  Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review.

Authors:  Bashaar Alibrahim; Mohammed I Aljasser; Baljinder Salh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04

Review 10.  [Prevention and conservative therapy of diverticular disease].

Authors:  E Kruse; L Leifeld
Journal:  Chirurg       Date:  2014-04       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.